Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: OPTIONS, Note the excercise date of Pohl's 1.5 million options

Feb 18, 2007 08:27AM

Feb 18, 2007 09:00AM
Under the terms of the Agreement, the Company granted Mr. Pohl the right, privilege and option ("Option") to purchase 1,500,000 shares of the common stock of the Company at an exercise price of $0.165 per share. The Option was fully vested upon grant and must be exercised within the earlier of (i) August 15, 2007, or (ii) three months after the first date that Mr. Pohl is no longer an officer or director of the Company.
Share
New Message
Please login to post a reply